Raymedica® to Present at the 2nd Annual Spine Technology Summit

MINNEAPOLIS, (April 23, 2007) — Raymedica, the Pioneer in Nucleus Arthroplasty technology, announced today that John J. Viscogliosi, Chairman and Chief Executive Officer, and Steven J. Seme, Vice President, will be presenting “HydraFlex™ Nucleus Arthroplasty™ Technology,” at the 2nd Annual Spine Technology Summit at the Berlin Marriott Hotel in Berlin, Germany on Monday, April 30, 2007 at 10:04 AM

About Raymedica
Raymedica, based in Minneapolis, Minnesota, is the Pioneer in Nucleus Arthroplasty having developed the world’s first nucleus replacement device in 1996.  Raymedica develops, manufactures and markets medical device systems designed to treat patients with degenerative disc disease that have been unresponsive to non-surgical treatment.  Raymedica’s products are currently available in many countries worldwide, but are limited to investigational use only in the United States. For more information, visit the Company's website at http://www.raymedica.com.